Cargando…

Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes

Detalles Bibliográficos
Autor principal:	Ye, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326288/ https://www.ncbi.nlm.nih.gov/pubmed/37425063 http://dx.doi.org/10.1016/j.apsb.2023.03.016

Ejemplares similares

Commentary: Educational intervention in type 2 diabetes
por: Singh, Raminder
Publicado: (2023)

Commentary on glucose reduction in type 2 diabetes (GRADE)
por: Lee, Yi‐Hong, et al.
Publicado: (2023)

Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’
por: Evans, Marc
Publicado: (2018)

Mini Review/Commentary: Growth Hormone Treatment in Children with Type 1 Diabetes
por: Bonfig, Walter, et al.
Publicado: (2019)

Commentary on Intraglumerular dysfunction predicts kidney failure in the type 2 diabetes
por: Wada, Jun
Publicado: (2021)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Commentary: A unified chain of command for organized team performance
por: Yoneyama, Fumiya, et al.
Publicado: (2020)

Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
por: Vitale, Cristiana, et al.
Publicado: (2016)

Commentary: COVID-19 and diabetes
por: Villabona, Carmen V.
Publicado: (2020)

Commentary: Burden of diabetic retinopathy
por: Bhattacharjee, Harsha, et al.
Publicado: (2021)

Commentary: Recent concepts of pathophysiology and advancements in treatment strategies of diabetic retinopathy
por: Singh, Ankur, et al.
Publicado: (2021)

Commentary: Transplanting lungs during a global respiratory pandemic
por: Mehaffey, J. Hunter, et al.
Publicado: (2022)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Commentary: Oral management of diabetic retinopathy
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Commentary: Diabetes eye screening in India
por: Singh, Raminder
Publicado: (2022)

Commentary: Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India
por: Mishra, Chitaranjan
Publicado: (2021)

A commentary on the VITAL study: Does vitamin D (receptor activation) protect against nephropathy in type 2 diabetes?
por: Okada, Shinichi, et al.
Publicado: (2011)

Commentary: From diabetic retinopathy toward diabetic retinal disease
por: Saurabh, Kumar, et al.
Publicado: (2021)

Commentary: Diabetic retinopathy and its correlation with other diabetic complications
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Commentary: Heteroplasmy in maternally inherited diabetes and deafness
por: Panchal, Bhavik, et al.
Publicado: (2020)

Improving Insulin Sensitivity With HDAC Inhibitor
por: Ye, Jianping
Publicado: (2013)

Commentary: One plus one does not always equal two: Mitochondrial cardioprotection
por: Guariento, Alvise, et al.
Publicado: (2021)

Commentary: COVID-19 disease is more than just a respiratory infection
por: Ahuja, Ashish, et al.
Publicado: (2021)

Commentary: Understanding the challenge of acute respiratory distress syndrome in the cardiothoracic surgical patient
por: Pulido, Juan N.
Publicado: (2021)

Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
por: Ferri, Claudio, et al.
Publicado: (2021)

Commentary: Imaging in macular telangiectasia type 2 – Correlating structural change with vision
por: Bhende, Muna
Publicado: (2021)

Commentary: Biosimilars in the treatment of retinopathy of prematurity
por: Soni, Tanvi, et al.
Publicado: (2023)

Commentary: Recognizing pupillary dysfunction in diabetic autonomic neuropathy
por: Sudhakar, Padmaja
Publicado: (2019)

Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders
por: Moreker, Mayur R
Publicado: (2020)

Commentary: Go with your gut: Evolving approaches in the treatment of type A dissection with visceral malperfusion
por: Ibrahim, Marina, et al.
Publicado: (2020)

Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
por: Lin, Chun‐Hsien, et al.
Publicado: (2020)

Commentary on the effects of gestational hypertension on new‐onset diabetes mellitus
por: Wang, Wen‐Chung, et al.
Publicado: (2013)

Commentary: Rapid assessment of avoidable blindness and diabetic retinopathy in India
por: Misra, Neha, et al.
Publicado: (2020)

Commentary: Subthreshold micropulse yellow laser in diabetic macular edema
por: Bansal, Mayank
Publicado: (2020)

Commentary for distribution and risk factors of postoperative endophthalmitis in people with diabetes
por: Mahendradas, Padmamalini, et al.
Publicado: (2021)

Commentary: Predictors of development and progression of diabetic retinopathy: A precis
por: Moharana, Bruttendu, et al.
Publicado: (2021)

Commentary: Shifting our focus to diabetic retinopathy is the need of the hour
por: Kohli, Piyush, et al.
Publicado: (2022)

Commentary: Treatment for Truncus Arteriosus Needs to Be Tailored
por: Lim, Hong-Gook
Publicado: (2023)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c3gf57m45kucjpsvjh94hq0cek